IGF1R and neoplasm: Daily intraperitoneal injection of metformin in a subcutaneous PC‐3 xenograft model reduced tumour growth and IGF‐1R mRNA expression which further supports the finding that metformin targets IGF‐1R signalling to inhibit PCa growth.46